Association of low CYP3A activity with p53 mutation and CYP2D6 activity with Rb mutation in human bladder cancer

Carcinogenesis

Volumn 17, Issue 5, 1996, Pages 1057-1062

  Romkes, Marjorie ^a   Chern, Herng Der ^a,d   Lesnick, Timothy G ^a   Becich, Michael J ^b   Persad, Raj ^c   Smith, Patrick ^c   Branch, Robert A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; DEBRISOQUINE; DRUG METABOLIZING ENZYME; MEPHENYTOIN; MUTANT PROTEIN; POLYCLONAL ANTIBODY; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER RISK; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HYDROXYLATION; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

AGED; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; GENES, P53; GENES, RETINOBLASTOMA; GLUTATHIONE TRANSFERASE; HUMANS; MIXED FUNCTION OXYGENASES; MUTATION; OXIDOREDUCTASES, N-DEMETHYLATING; URINARY BLADDER NEOPLASMS;

EID: 0029996879     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.5.1057     Document Type: Article

References (48)

1. Gilbert,H.A., Logan,J.L., Kagan,A.R. et al. (1978) The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading. J. Urology, 119, 488-492.
2. Lianes,P., Orlow,I., Zhang,Z.-F., Oliva,M.R., Sarkis,A.S., Reuter,V.E. and Cordon-Cardo,C. (1994) Altered patterns of MDM2 and TP53 expression in human bladder cancer. J. Natl Cancer Inst., 86, 1325-1330.
3. Cardon-Cardo,C., Dalbasni,G., Sarkis,A.S., Reuter,V.E. (1994) Genetic alterations associated with bladder cancer. Important Adv. Oncol., 71-83.
4. Levine,A.J., Momand,J. and Finley,C.A. (1991) The p53 tumor suppressor gene. Nature (Lond.), 351, 453-456.
5. Hollstein,M., Sidransky,D., Vogelstein,B. and Harris,C.C. (1991) p53 Mutations in human cancer. Science, 253, 49-53.
6. Oren,M. (1992) p53: The ultimate tumor suppressor gene? FASEB J., 6, 3169-3176.
7. Leonard,C.J., Canman,C.E. and Kastan,M.B. (1995) The role of p53 in cell-cycle control and apoptosis: implications for cancer. Important Adv. Oncol. 33-42.
8. Takahashi,R., Hashimoto,T., Xu,H.-J. et al. (1991) The retinoblastoma gene functions as a growth and tumor suppressor gene in human carcinoma cells. Proc. Natl Acad. Sci. USA, 88, 5257-5261.
9. Logothetis,C.J., Xu,H.-J., Ro,J.Y., Hu,S.X., Sahin,A., Ordonez,N. and Benedict,W.F. (1992) Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer . J. Natl Cancer Inst., 84. 1256-1261.
10. Cordon-Cardo,C., Wartinger,D., Petrylak,D., Dalbagni,G., Fair,W.R., Fuks,Z. and Reuter,V.E. (1992) Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J. Natl Cancer Inst., 84. 1251-1256.
11. Zarbl,H., Sukumar,S., Arthur,A.L., Martin-Zanca,D. and Barbacid,M. (1985) Direct mutagenesis of N-nitro-N-methylureas during initiation of mammary carcinogenesis in rats. Nature (Lond.), 315, 382-385.
12. Fujimoto,Y., Hampton,L.L., Wirth,P.J., Wang,N.J., Xie,J.P. and Thorgeirsson,S.S. (1994) Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinoma in China. Cancer Res., 54, 281-285.
13. Spruck,C.H., Rideout,W.M., Olumi,A.F. et al. (1993) Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Cancer Res., 53, 1162-1166.
14. Anton-Culver,H. (1991) Smoking and other risk factors associated with the stase and age of diagnosis of colon and rectum cancers. Cancer Detect. Prev., 15. 345-350.
15. Heineman,E.F., Zahm.S.H., McLaughlin,J.K. and Vaught,J.B. (1994) Increased risk of colorectal cancer among smokers: results of a 26-year follow-up of US veterans and a review. Int. J. Cancer, 59. 728-738.
16. Giovannucci,E., Rimm,E.B., Stampfer,M.J., Colditz,G.A., Ascherio,A., Keamey,J. and Willett,W.C. (1994) A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in US men. J. Natl Cancer Inst., 86, 183-191.
17. Giovannucci,E., Colditz,G.A., Stampfer,M.J., Hunter,D., Rosner,B.A., Willett,W.C. and Speizer,F.E. (1994) A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in US women. J. Natl Cancer Inst., 86, 192-199.
18. Fleming,C.M., Persad,R., Kaisary,A., Smith,P., Adedoyin,A., Porter,J., Wilkinson,G.R. and Branch,R.A. (1994) Low activity of dapsone hydroxylation as a susceptibility risk factor in aggressive bladder cancer. Pharmacogenetics, 4, 199-207.
19. Kaisary,A., Smith,P.J.B., Jacqz,E., McAllister,C.B., Wilkinson,G.R., Ray,W.A. and Branch,R.A. (1987) Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors. Cancer Res., 47, 5488-5493.
20. Chem,H.D., Romkes-Sparks,M., Hu,J.J., Persad,R.A., Sibley,G.A., Smith,P.J.B. and Branch,R.A. (1994) Homozygous deleted genotype of glutathione S-transferase M1 increases susceptibility to aggressive bladder cancer. Proc. Ann. Meeting. Am. Assoc. Cancer Res., 35, 285.
21. Bell,D.A., Taylor,J.A., Paulson,D.F., Robertson,C.N., Mohler,J.L. and Lucier,G.W. (1993) Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl Cancer Inst., 85. 1159-1164.
22. Sidransky,D., Von Eschenbach,A., Tsai,Y.C. et al. (1991) Identification of p53 gene mutations in bladder cancers and urine samples. Science. 252. 706-709.
23. Borland,R.N., Brendler,C.B. and Isaacs,W.B. (1992) Molecular biology of bladder cancer. Hepatol. Oncol. Clinics of N. Am., 6, 31-39.
24. Wolff,J.M., Stephenson,R.N., Jakse.G., Habib,F.K. (1994) Retinoblastoma and p53 genes as prognostic indicators in urological oncology. Urol, Int., 53. 1-5.
25. Fujimoto,K., Yamada,Y., Okajima,E., Kakizoe,T., Sasaki,H., Sugimura,T. and Terada,M. (1992) Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res., 52, 1393-1398.
26. Sarkis,A.S., Dalbagni,G., Cordon-Cardo,C., Zhang,Z.F., Sheinfeld,J., Fair,W.R., Heir,H.W. and Reuter,V.E. (1993) Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J. Natl Cancer Inst., 85, 53-59.
27. Kusser,W.C., Miao,X., Glickman,B.W. et al. (1994) p53 Mutations in human bladder cancer. Environ. Mol. Mutagenesis., 24, 156-160.
28. Uchida,T., Wadam,C., Ishida,H., Wang,C., Egawa,S., Yokoyama,E., Kameya,T. and Koshiba,K. (1995) p53 mutations and prognosis in bladder tumors. J. Urology, 153, 1097-1104.
29. Horowitz,J.M., Park,S.H., Bogenmann,E., Cheng,J.C., Yandell,D.W., Kaye,F.J., Minna,J.D., Dryja,T.P. and Weinberg,R.A. (1990) Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl Acad. Sci. USA. 87. 2775-2779.
30. Miyamoto,H., Shuin,T., Torigoe,S., Iwasaki,Y.and Kubota,Y. (1995) Retinoblastoma gene mutations in human bladder cancer. Br. J. Cancer. 71, 831-835.
31. Esrig,D., Elmajian,D., Groshen,S., Freeman,J.A., Stein,J.P., Chen,S.C., Nichols,P.W., Skinner,D.G., Jones,P.A. and Cote,R.J. (1994) Accumulation of nuclear p53 and tumor progression in bladder cancer. New Engl. J. Med., 331: 1259-1264.
32. Kawajiri,K., Watanabe,J., Eguchi,H. and Hayashi,S.-I. (1995) Genetic polymorphisms of drug-metabolizing enzymes and lung cancer susceptibility. Pharmacogenetics. 5. S70-S73.
33. Bell,D.A., Thompson,C.L., Taylor,J., Miller,C.R., Perera,F., Hsieh,L.L. and Lucier,G.W. (1992) Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase mu. Environ., Health Perspect., 98, 113-117.
34. Bergkvist,A., Ljungqvist,A. and Moberger,G. (1965) Classification of bladder tumors based on the cellular pattern. Acta Chir. Scan., 130. 371-379.
35. Ash,J.E. (1940) Epithelial tumors of the bladder. J. Urology, 44. 135-145.
36. Mostofi,F.K., Sobin,L.H. and Torloni,H. (1973) International Histological Classification of Tumors. Geneva. World Health Organization, no. 10.
37. Chem,H.D., Romkes,M., Adedoyin,A. et al. (1996) N-acetyltransferase slow acetylator phenotype as a susceptibility risk factor of human bladder cancer, in preparation.
38. Fleming,C., Persad,R., Chem,H.D. et al. (1995) Environmental procarcinogen hypothesis of bladder cancer in man: dapsone hydroxylation as a susceptibility risk factor for aggressive bladder cancer. Urol. Oncol., submitted.
39. Kroft,S.H. and Oyasu,R. (1994) Urinary bladder cancer: mechanisms of development and progression. Lab. Invest., 71, 158-174.
40. Dunn,J.M., Hastrich,D.J., Newcomb,P., Webb,J.C., Maitland,N.J. and Farndon,J.R. (1993) Correlation between p53 mutations and antibody staining in breast carcinoma. Br. J. Surg., 80, 1410-1412.
41. Lohmann,D., Ruhri,C., Schmitt,M., Graeff,H. and Hofler,H. (1993) Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Occurrence of false-positives and false-negatives. Diag. Mol. Pathol., 2, 36-41.
42. Thompson,A.M., Anderson,T.J., Condie,A., Prosser,J., Chetty,U., Carter,D.C., Evans,H.J. and Steel,C.M. (1992) p53 Allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters. Int. J. Cancer. 50, 528-532.
43. Umekita,Y., Kobayashi,K., Saheki,T. and Yoshida,H. (1994) Nuclear accumulation of p53 protein correlates with mutations in the p53 gene on archival paraffin-embedded tissues of human breast cancer. Jpn J. Cancer Res., 85, 825-830.
44. Hurlimann,J., Chaubert,P. and Benhattar,J. (1994) p53 Gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between immunohistochemical and molecular biology techniques. Modern Pathol., 7, 423-428.
45. Lehman,T.A., Bennett,W.P., Metcalf,R.A. et al. (1991) p53 Mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res., 51, 4090-4096.
46. Bodner,S.M., Minna,J.D., Jensen,S.M. et al. (1992) Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene, 7, 743-749.
47. Dalbagni,G., Presti,J.C., Reuter,V.E., Zhang,Z.-F., Sarkis,A.S., Fair,W.R. and Cordon-Cardo,C. (1993) Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer. Diag. Mol. Pathol., 2, 4-13.
48. Cordon-Cardo,C., Dalbagni,G., Saez,G.T., Oliva,M.R., Zhang,Z.-F., Rosai,J., Reuter,V.E. and Pellicer,A. (1994) p53 Mutations in human bladder cancer genotypic versus phenotypic patterns. Int. J. Cancer, 56, 347-353.